Shen, Jiaqi http://orcid.org/0000-0002-7435-4106
Geng, Lequn http://orcid.org/0000-0003-3838-6191
Li, Xingyu http://orcid.org/0000-0002-2456-8042
Emery, Catherine http://orcid.org/0000-0003-0628-9282
Kroning, Kayla
Shingles, Gwendolyn
Lee, Kerry
Heyden, Matthias
Li, Peng http://orcid.org/0000-0002-8992-0350
Wang, Wenjing http://orcid.org/0000-0001-6025-9848
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R21AG07200901)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (DP2MH132939, F31MH12915001, R01AT011652)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA05320001)
Research Corporation for Scientific Advancement (# 28431, Grant #27360)
University of Michigan
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP2MH132939)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R01AT011652)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL156989)
Article History
Received: 3 January 2021
Accepted: 21 October 2022
First Online: 8 December 2022
Competing interests
: The authors declare the following competing interests. A patent application has been filed by W.W., P.L., J.S., and L.G. with title ‘Chemogenetic Regulation of Peptide Function,’ U.S. Provisional Patent Application No. 63/329,736, filed April 11, 2022; applicants: the Regents of the University of Michigan; patent pending. All other authors declare no competing interests.